<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta charset="utf-8"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><title>Utility based optimal phase II/III drug development planning — drugdevelopR • drugdevelopR</title><script src="../deps/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><link href="../deps/bootstrap-5.3.1/bootstrap.min.css" rel="stylesheet"><script src="../deps/bootstrap-5.3.1/bootstrap.bundle.min.js"></script><link href="../deps/font-awesome-6.5.2/css/all.min.css" rel="stylesheet"><link href="../deps/font-awesome-6.5.2/css/v4-shims.min.css" rel="stylesheet"><script src="../deps/headroom-0.11.0/headroom.min.js"></script><script src="../deps/headroom-0.11.0/jQuery.headroom.min.js"></script><script src="../deps/bootstrap-toc-1.0.1/bootstrap-toc.min.js"></script><script src="../deps/clipboard.js-2.0.11/clipboard.min.js"></script><script src="../deps/search-1.0.0/autocomplete.jquery.min.js"></script><script src="../deps/search-1.0.0/fuse.min.js"></script><script src="../deps/search-1.0.0/mark.min.js"></script><!-- pkgdown --><script src="../pkgdown.js"></script><meta property="og:title" content="Utility based optimal phase II/III drug development planning — drugdevelopR"><meta name="description" content="The drugdevelopR package enables utility based planning of phase II/III drug development programs with optimal sample size allocation and go/no-go decision rules. The assumed true treatment effects can be assumed fixed (planning is then also possible via user friendly R Shiny App: drugdevelopR) or modelled by a prior distribution. The R Shiny application prior visualizes the prior distributions used in this package. Fast computing is enabled by parallel programming."><meta property="og:description" content="The drugdevelopR package enables utility based planning of phase II/III drug development programs with optimal sample size allocation and go/no-go decision rules. The assumed true treatment effects can be assumed fixed (planning is then also possible via user friendly R Shiny App: drugdevelopR) or modelled by a prior distribution. The R Shiny application prior visualizes the prior distributions used in this package. Fast computing is enabled by parallel programming."></head><body>
    <a href="#main" class="visually-hidden-focusable">Skip to contents</a>


    <nav class="navbar navbar-expand-lg fixed-top bg-light" data-bs-theme="light" aria-label="Site navigation"><div class="container">

    <a class="navbar-brand me-2" href="../index.html">drugdevelopR</a>

    <small class="nav-text text-muted me-auto" data-bs-toggle="tooltip" data-bs-placement="bottom" title="">1.0.2</small>


    <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
      <span class="navbar-toggler-icon"></span>
    </button>

    <div id="navbar" class="collapse navbar-collapse ms-3">
      <ul class="navbar-nav me-auto"><li class="active nav-item"><a class="nav-link" href="../reference/index.html">Reference</a></li>
<li class="nav-item dropdown">
  <button class="nav-link dropdown-toggle" type="button" id="dropdown-articles" data-bs-toggle="dropdown" aria-expanded="false" aria-haspopup="true">Articles</button>
  <ul class="dropdown-menu" aria-labelledby="dropdown-articles"><li><a class="dropdown-item" href="../articles/Introduction-to-drugdevelopR.html">Introduction to planning phase II and phase III trials with drugdevelopR</a></li>
    <li><a class="dropdown-item" href="../articles/Package_validation.html">Package validation</a></li>
    <li><hr class="dropdown-divider"></li>
    <li><a class="dropdown-item" href="../articles/index.html">More articles...</a></li>
  </ul></li>
<li class="nav-item"><a class="nav-link" href="../news/index.html">Changelog</a></li>
      </ul><ul class="navbar-nav"><li class="nav-item"><form class="form-inline" role="search">
 <input class="form-control" type="search" name="search-input" id="search-input" autocomplete="off" aria-label="Search site" placeholder="Search for" data-search-index="../search.json"></form></li>
<li class="nav-item"><a class="external-link nav-link" href="https://github.com/Sterniii3/drugdevelopR/" aria-label="GitHub"><span class="fa fab fa-github fa-lg"></span></a></li>
      </ul></div>


  </div>
</nav><div class="container template-reference-topic">
<div class="row">
  <main id="main" class="col-md-9"><div class="page-header">

      <h1>Utility based optimal phase II/III drug development planning</h1>
      <small class="dont-index">Source: <a href="https://github.com/Sterniii3/drugdevelopR/blob/HEAD/R/drugdevelopR.R" class="external-link"><code>R/drugdevelopR.R</code></a></small>
      <div class="d-none name"><code>drugdevelopR.Rd</code></div>
    </div>

    <div class="ref-description section level2">
    <p>The drugdevelopR package enables utility based planning of phase II/III drug development programs with optimal sample size allocation and go/no-go decision rules. The assumed true treatment effects can be assumed fixed (planning is then also possible via user friendly R Shiny App: <a href="https://web.imbi.uni-heidelberg.de/drugdevelopR/" class="external-link">drugdevelopR</a>) or modelled by a prior distribution. The R Shiny application <a href="https://web.imbi.uni-heidelberg.de/prior/" class="external-link">prior</a> visualizes the prior distributions used in this package. Fast computing is enabled by parallel programming.</p>
    </div>

    <div class="section level2">
    <h2 id="ref-usage">Usage<a class="anchor" aria-label="anchor" href="#ref-usage"></a></h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span><span class="fu">drugdevelopR</span><span class="op">(</span><span class="op">)</span></span></code></pre></div>
    </div>

    <div class="section level2">
    <h2 id="drugdevelopr-package-and-r-shiny-app">drugdevelopR package and R Shiny App<a class="anchor" aria-label="anchor" href="#drugdevelopr-package-and-r-shiny-app"></a></h2>


<p>The drugdevelopR package provides the functions to plan optimal phase II/III drug development programs with</p><ul><li><p>time-to-event endpoint (<code><a href="optimal_tte.html">optimal_tte</a></code>),</p></li>
<li><p>binary endpoint (<code><a href="optimal_binary.html">optimal_binary</a></code>) and</p></li>
<li><p>normally distributed endpoint (<code><a href="optimal_normal.html">optimal_normal</a></code>),</p></li>
</ul><p>where the treatment effect is assumed fixed or modelled by a <a href="https://web.imbi.uni-heidelberg.de/prior/" class="external-link">prior</a>. In these settings, optimal phase II/III drug development planning with fixed assumed treatment effects can also be done with the help of the R Shiny application <a href="https://web.imbi.uni-heidelberg.de/basic/" class="external-link">basic</a>. Extensions to the basic setting are</p><ul><li><p>optimal planning of programs including methods for discounting of phase II results (function: <code><a href="optimal_bias.html">optimal_bias</a></code>, App: <a href="https://web.imbi.uni-heidelberg.de/bias/" class="external-link">bias</a>),</p></li>
<li><p>optimal planning of programs with several phase III trials (function: <code><a href="optimal_multitrial.html">optimal_multitrial</a></code>, App: <a href="https://web.imbi.uni-heidelberg.de/multitrial/" class="external-link">multitrial</a>) and</p></li>
<li><p>optimal planning of programs with multiple arms (function: <code><a href="optimal_multiarm.html">optimal_multiarm</a></code>, App: <a href="https://web.imbi.uni-heidelberg.de/multiarm/" class="external-link">multiarm</a>).</p></li>
</ul><p>The R Shiny App <a href="https://web.imbi.uni-heidelberg.de/drugdevelopR/" class="external-link">drugdevelopR</a> serves as homepage, navigating the different parts of drugdevelopR via links.</p>
    </div>
    <div class="section level2">
    <h2 id="references">References<a class="anchor" aria-label="anchor" href="#references"></a></h2>
    <p>Kirchner, M., Kieser, M., Goette, H., &amp; Schueler, A. (2016). Utility-based optimization of phase II/III programs. Statistics in Medicine, 35(2), 305-316.</p>
<p>Preussler, S., Kieser, M., and Kirchner, M. (2019). Optimal sample size allocation and go/no-go decision rules for phase II/III programs where several phase III trials are performed. Biometrical Journal, 61(2), 357-378.</p>
<p>Preussler, S., Kirchner, M., Goette, H., Kieser, M. (2019). Optimal designs for phase II/III drug development programs including methods for discounting of phase II results. Submitted to peer-review journal.</p>
<p>Preussler, S., Kirchner, M., Goette, H., Kieser, M. (2019). Optimal designs for multi-arm Phase II/III drug development programs. Submitted to peer-review journal.</p>
    </div>

  </main><aside class="col-md-3"><nav id="toc" aria-label="Table of contents"><h2>On this page</h2>
    </nav></aside></div>


    <footer><div class="pkgdown-footer-left">
  <p>Developed by Stella Erdmann, Johannes Cepicka, Marietta Kirchner, Meinhard Kieser, Lukas D. Sauer.</p>
</div>

<div class="pkgdown-footer-right">
  <p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.1.1.</p>
</div>

    </footer></div>





  </body></html>

